Synthesis, evaluation and structure-activity relationship of new 3-carboxamide coumarins as FXIIa inhibitors
- 1 March 2016
- journal article
- Published by Elsevier in European Journal of Medicinal Chemistry
- Vol. 110, 181-194
Abstract
No abstract availableKeywords
Funding Information
- F.R.S.-FNRS (2.4520.11)
This publication has 49 references indexed in Scilit:
- Factor XI and contact activation as targets for antithrombotic therapyJournal of Thrombosis and Haemostasis, 2015
- New agents for thromboprotectionHamostaseologie, 2015
- In vivo roles of factor XIIBlood, 2012
- Factor XI and XII as antithrombotic targetsCurrent Opinion in Hematology, 2011
- The procoagulant and proinflammatory plasma contact systemSeminars in Immunopathology, 2011
- Triggers, targets and treatments for thrombosisNature, 2008
- The intrinsic pathway of coagulation: a target for treating thromboembolic disease?Journal of Thrombosis and Haemostasis, 2007
- Targeting coagulation factor XII provides protection from pathological thrombosis in cerebral ischemia without interfering with hemostasisJournal of Experimental Medicine, 2006
- The intrinsic pathway of coagulation is essential for thrombus stability in miceBlood Cells, Molecules, and Diseases, 2006
- Defective thrombus formation in mice lacking coagulation factor XIIJournal of Experimental Medicine, 2005